The management of cancer patients has changed due to the considerably more frequent use of immune checkpoint inhibitors (ICPIs). However, the use of ICPI has a risk of side effects, particularly...
Endocr Relat Cancer - issue: 2 - volume: 26 - pages: G1-G18.